Company Overview and News
KUALA LUMPUR: Comfort Gloves shares rise 9% after the group clarified that its operations were not disrupted by the US Food and Drug Administration’s (FDA) action.
KUALA LUMPUR: Ni Hsin Resources Bhd , Caely Holdings Bhd , Comfort Gloves Bhd , Suria Capital Holdings Bhd and MMC Corp Bhd are among the stocks to watch on Monday, according to JF Apex Research.
KUALA LUMPUR, March 30 — Bursa Malaysia rebounded to open higher today, lifted by buying interest in selected heavyweights, dealers said.
Bigger shipment: Total export value of rubber gloves from Malaysia is due to grow by RM3bil to RM16.2bil, despite rising raw material, natural gas and labour costs.
UEM Sunrise Bhd has proposed the disposal of 28.995 acres of freehold agricultural lands in Iskandar Puteri, Johor Baru, to Kimlun Corp Bhd for a total consideration of RM82.1mil.
KUALA LUMPUR: Glove counters rally hit a speed bump in early trade on Thursday with some profit-taking kicking in.
KUALA LUMPUR: JF Apex expects Poh Huat Resources Holdings Bhd , Westports Holdings Bhd , Dagang NeXchange Bhd (DNeX) and Comfort Gloves Bhd to be among the stocks to watch on Thursday.
An investor monitors share market prices at a brokerage firm in Kuala Lumpur. — Reuters picKUALA LUMPUR, Oct 24 — Bursa Malaysia extended yesterday’s gains to open higher today despite Wall Street’s broadly lower overnight close.
An investor monitors share market prices at a brokerage firm in Kuala Lumpur. — Reuters picKUALA LUMPUR, June 22 ― Bursa Malaysia ended the morning session higher today boosted by gains in Genting and selected blue chips and in tandem with the stronger Asian equities markets, dealers said.
KUALA LUMPUR, June 22 — Bursa Malaysia rebounded to open slightly higher this morning from yesterday's losses as bargain hunting emerged to boost demand.
COMFORT Gloves Bhd (Comfort; Code: 2127) shares dropped to a low of 64.5 sen on the first trading day of this year, the worst level in almost five months during the recent correction process due to persistent profit-taking liquidation pressure.
KUALA LUMPUR (Dec 20): Shares of Comfort Gloves Bhd gained 3.01% this morning after its net profit for the third quarter ended Oct 31, 2016 (3QFY17) rose 15.6% to RM8.3 million or 1.81 sen per share from RM7.2 million or 1.58 sen per share a year ago on increased revenue and a cost reduction programme during the year.
KUALA LUMPUR (Dec 20): The FBM KLCI could struggle to advance and drift sideways today despite the overnight gains at most global markets, given the lack of fresh catalysts as well as the still weak ringgit.
KUALA LUMPUR (Dec 6): MIDF Research has downgraded the rubber glove sector to "neutral" (from positive) after taking into account the earnings recorded by most of the glove players.
KUALA LUMPUR, Feb 3 — Bursa Malaysia closed sharply lower today weighed by losses in oil and gas-related counters amid weaker global oil prices, dealers said. At 5pm, the benchmark FTSE Bursa Malaysia KLCI fell 19.88 points to 1,633.30 from its
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...
2018-05-19 - Asif
Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...
2018-05-17 - Asif
Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...